References
- BonaaKHNjolstadIUelandPMHomocysteine lowering and cardiovascular events after acute myocardial infarctionN Engl J Med200635415788816531614
- CranfordLSDiagnosis, prevention and intervention for the metabolic syndromeAm J Cardiol2003923542
- DankerRChetritALubinFLife-style habits and homocysteine levels in an elderly populationAging Clin Exp Res2004164374215739593
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP)Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ATP III)JAMA200128524869711368702
- HajerGRvan der GraafYOlijhoekJKLevels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndromeHeart2007932162016952974
- LonnEHeldCArnoldJMRationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients; the Heart Outcomes Prevention Evaluation (HOPE)-2 trialCan J Cardiol200622475316450017
- MalinowMRBostomAGKraussRMHomocyst(e)ine, diet, and cardiovascular diseases. A statement for healthcare professionals from the Nutrition Committee, American Heart AssociationCirculation199999178829884399
- NinomiyaJKL’ItalienGCriquiMHAssociation of the Metabolic Syndrome with history of myocardial infarction and stroke in the Third National Health and Nutritional Examination SurveyCirculation200410942614676144
- SiragusaSMalatoACignaVThe risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitaminsThromb Res2007in press
- VirtanenJKVoutilainenSAlfthanGHomocysteine as a risk factor for CVD mortality in men with other CVD risk factors: the Kuopio Ischaemic Heart Disease Risk Factors (KIHD) StudyJ Intl Med200525725562